Sapna Patel, BA, MD

Sapna Patel, MD of University of Colorado Cancer Center

Sapna Patel, MD, is a professor in the Division of Medical Oncology, the leader of the Cutaneous Oncology Program, and the William Robinson Endowed Chair in Cancer Research at the University of Colorado Cancer Center.

Articles by Sapna Patel, BA, MD

The panelists emphasize the importance of obtaining tissue for BRAF-mutation testing and dedicated tissue tracking in patients with metastatic melanoma, with immunohistochemistry followed by confirmatory next-generation sequencing, and discuss the promise of liquid biopsies like ctDNA as a future biomarker tracking modality.

When a patient with metastatic melanoma patient tests negative for the BRAF V600E mutation, doctors recommend sending the sample for next-generation sequencing testing which can take 2-3 weeks, during which time they may start immunotherapy if the patient has aggressive disease, but ideally should wait for results to guide treatment.